Pharmaceutical Technology13h
South Korean company Dong-A ST wins FDA approval for Stelara biosimilar
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for the treatment of certain autoimmune diseases.
Pharmaceutical Technology18h
XtalPi’s AI biologics discovery platform licensed to Janssen Biotech
XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen Biotech for advanced biotherapeutics ...
Pharmaceutical Technology15h
FDA AdCom votes in favour of Stealth’s Barth syndrome drug
The Cardiovascular and Renal Drugs Advisory Committee voted 10-6 in support of Stealth’s elamipretide for the ultra-rare ...
Pharmaceutical Technology22h
Booster Therapeutics to develop proteasome activator medicines
Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for ...
Pharmaceutical Technology17h
Global awareness and geographic variations of plaque psoriasis
Plaque psoriasis is a chronic condition that affects millions yet is often misunderstood or underappreciated in terms of its ...
Pharmaceutical Technology16h
Roche wins first-line approval for PI3K inhibitor combo in breast cancer
The US FDA approved Itovebi in combination with Pfizer’s Ibrance and AstraZeneca’s Faslodex for certain breast cancer ...
Pharmaceutical Technology11h
CPHI Europe: Targeting supply chain bottlenecks key for cell and gene therapies
At CPHI Europe, Angela Vollstedt, global director of Cell & Gene Therapies at Novartis discussed scale up strategies for cell ...